[Therapeutic influence on the blood lipids in manifest coronary sclerosis].
作者信息
Aschenbeck G
出版信息
Rev Bras Med. 1971 Dec;28(12):653-8.
PMID:4259647
Abstract
摘要
相似文献
1
[Therapeutic influence on the blood lipids in manifest coronary sclerosis].[对显性冠状动脉硬化血脂的治疗影响]
Rev Bras Med. 1971 Dec;28(12):653-8.
2
[Value of determining serum cholesterol levels in patients with coronary heart disease].[测定冠心病患者血清胆固醇水平的价值]
Ned Tijdschr Geneeskd. 1997 Dec 27;141(52):2545-8.
3
[The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Z Gesamte Inn Med. 1966 Mar 15;21(6):169-72.
4
5
[The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].[1,4-二咖啡酰奎宁酸对动脉粥样硬化患者血液脂质成分的作用]
Minerva Med. 1969 Nov 14;60(91):4514-8.
6
Rational prescribing of statins.
Practitioner. 2001 Nov;245(1628):957-9, 962-3.
7
[Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].[脂质代谢紊乱的治疗药物——特别提及动脉疾病]
Nihon Rinsho. 1970 Mar 25;28 Suppl:696-9.
8
Inhibition of atherosclerosis in cholesterol-fed rabbits by a heparitin sulfate. Preliminary communication.硫酸乙酰肝素对喂胆固醇家兔动脉粥样硬化的抑制作用。初步报告。
Atherosclerosis. 1971 Jan-Feb;13(1):103-9. doi: 10.1016/0021-9150(71)90011-6.
9
10
Measures to reduce the serum lipid levels in coronary heart disease.
Med Clin North Am. 1968 Sep;52(5):1249-60.
Zotero 插件